Skip to main content Back to Top


Fluorescein Sodium and Benoxinate Hydrochloride Ophthalmic Solution

Products Affected - Description

    • Flurox solution, OCuSOFT, 0.25%/0.4%, 5 mL bottle, 1 count, NDC 54799-0508-05

Reason for the Shortage

    • OCuSOFT has discontinued Flurox.
    • Altaire is the sole supplier of fluorescein/benoxinate ophthalmic solution.

Available Products

    • Altafluor solution, Altaire, 0.25%/0.4%, 5 mL bottle, 1 count, NDC 59390-0206-05

Estimated Resupply Dates

    • Altaire has Altafluor available.

Implications for Patient Care

    • Fluorescein/benoxinate and fluorescein/proparacaine ophthalmic solutions are combinations of a disclosing agent and a fast acting anesthetic that has a short duration of action.

Alternative Agents & Management

    • Fluorescein/proparacaine ophthalmic solution is available.
    • Fluorescein/proparacaine and fluorescein/benoxinate areused in tonometry, corneal foreign body removal, suture removal, and other corneal or conjunctival procedures. They are dosed similarly for these indications.


Updated June 27, 2018 by Megan Dryer, PharmD. Created May 3, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins